The drug candidate is developed based on SNAC technology. Novo Nordisk, a subsidiary of Novo Holdings AS, is a healthcare company with focus on discovering, developing, and manufacturing biological ...
Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...
A new study confirms a link between Novo Nordisk's Ozempic and an increased risk of NAION, a rare, irreversible form of ...
With drugs like Novo Nordisk's Wegovy becoming household names over the last couple of years, it's no surprise that there are ...
Americans pay more for health care but don't get better results. Why? The blame goes well beyond insurance companies.
Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...
Novo Holdings will proceed with its $16.5 billion acquisition of Catalent, the companies announced Saturday, after the ...
Novo Nordisk (NVO) announced that as of today, all regulatory closing conditions relating to the review of its pending acquisition of Catalent ...
Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback